Global Dermal Grafts Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Dermal grafting is the procedure in which the part of the skin is replaced with the skin from other parts of the body. A dermal graft is used to replace damaged or missing skin or to provide a temporary wound covering. Dermal grafting is performed or recommended for skin infections, injury, deep burns, skin cancer, pressure ulcers and reconstructive surgeries. There are two types of skin grafts Viz. the split-level thickness and full thickness. Split-level thickness includes removal of dermal and epidermal layers of the skin and full-thickness grafts involve removal of muscles and blood vessels. Patients with deeper tissue loss need a full-thickness skin graft to cover the wound. This requires an entire thickness of skin from the donor site, not just the top two layers.
Dermal grafts market is driven by rise in the incidence of burns, accidents and surgeries requiring removal of skin. In addition factors such as skin loss due to cancer and infection are boosting the demand for dermal grafts. According to Skin Cancer Foundation, each year over 5.4 Mn cases of non-melanoma skin cancer are reported and over 3.3 Mn people are treated for the same in the U.S. Furthermore, technological advances in dermatomes such as electric and air dermatomes, increased accuracy and control by using exchangeable blades are the factors expected to bolster skin grafts market over the forecast period. However, complications of dermal grafts such as infection, pain, high cost of the procedure, and tissue rejection are some of the factors hindering the growth of the global dermal grafts market.
Dermal grafts market segmented on the basis of equipment, graft type, thickness, application, equipment and end-user
Based on equipment, skin grafts market is segmented into
Geographically, dermal grafts market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts for the significant market share owing to favourable reimbursement policies and higher healthcare expenditure. Adaptation of new technologies and increased skin related diseases are boosting the North America dermal grafts market. Europe dermal grafts market driven by large disposable income and rising awareness of newer technologies in dermal grafting among key stakeholders. Asia Pacific region is projected to have the fastest growth and is expected to lead by growing economies such as India and China. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to show minimal growth rate due to poor healthcare infrastructure and market penetration.
Some of the players in dermal grafts market include Organogenesis, Inc. (U.S.), Stratatech Corp. (U.S), Avita Medical (U.K.), ConvaTec Group plc. (U.K.), Coloplast (Denmark), B. Braun Holding GmbH & Co. KG (B.Braun Melsungen AG) (Germany), Medtronic (Stratatech Corporation) (U.S.), Zimmer Biomet. (U.S.), Nouvag AG (Switzerland), Tissue Regenix Group PLC (U.K), and Allergan Plc (Ireland)
In February 2017, Allergan plc, acquired LifeCell Corporation, a leading regenerative medicine company. LifeCell Corporation portfolio include, alloderm, a human allograft tissue matrix used in breast reconstruction post-mastectomy, and revolve, a single use high-volume fat grafting device used in plastic and reconstructive procedures. Additionally, LifeCell markets strattice, porcine based tissue matrix used in complex abdominal wall repair and for the surgical repair of damaged or ruptured soft tissue.
In January 2016, Integra LifeSciences Corporation’s omnigraft dermal regeneration matrix received new indication from the U.S. Food and Drug Administration (U.S. FDA) to treat certain diabetic foot ulcers
REPORT OUTLINE:
Dermal grafts market is driven by rise in the incidence of burns, accidents and surgeries requiring removal of skin. In addition factors such as skin loss due to cancer and infection are boosting the demand for dermal grafts. According to Skin Cancer Foundation, each year over 5.4 Mn cases of non-melanoma skin cancer are reported and over 3.3 Mn people are treated for the same in the U.S. Furthermore, technological advances in dermatomes such as electric and air dermatomes, increased accuracy and control by using exchangeable blades are the factors expected to bolster skin grafts market over the forecast period. However, complications of dermal grafts such as infection, pain, high cost of the procedure, and tissue rejection are some of the factors hindering the growth of the global dermal grafts market.
Dermal grafts market segmented on the basis of equipment, graft type, thickness, application, equipment and end-user
Based on equipment, skin grafts market is segmented into
- Dermatomes
- Knives Dermatomes
- Electric Dermatomes
- General Surgical Instruments
- Consumables
- Air Dermatomes
- Autologous
- Isogenic
- Allogeneic
- Xenogeneic
- Prosthetic
- Split Thickness
- Full Thickness
- Composite Graft
- Burns
- Extensive Wound
- Skin Cancer
- Infection
- Others
- Hospitals
- Dermatology Clinics
- Ambulatory Surgical Centers
Geographically, dermal grafts market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts for the significant market share owing to favourable reimbursement policies and higher healthcare expenditure. Adaptation of new technologies and increased skin related diseases are boosting the North America dermal grafts market. Europe dermal grafts market driven by large disposable income and rising awareness of newer technologies in dermal grafting among key stakeholders. Asia Pacific region is projected to have the fastest growth and is expected to lead by growing economies such as India and China. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to show minimal growth rate due to poor healthcare infrastructure and market penetration.
Some of the players in dermal grafts market include Organogenesis, Inc. (U.S.), Stratatech Corp. (U.S), Avita Medical (U.K.), ConvaTec Group plc. (U.K.), Coloplast (Denmark), B. Braun Holding GmbH & Co. KG (B.Braun Melsungen AG) (Germany), Medtronic (Stratatech Corporation) (U.S.), Zimmer Biomet. (U.S.), Nouvag AG (Switzerland), Tissue Regenix Group PLC (U.K), and Allergan Plc (Ireland)
In February 2017, Allergan plc, acquired LifeCell Corporation, a leading regenerative medicine company. LifeCell Corporation portfolio include, alloderm, a human allograft tissue matrix used in breast reconstruction post-mastectomy, and revolve, a single use high-volume fat grafting device used in plastic and reconstructive procedures. Additionally, LifeCell markets strattice, porcine based tissue matrix used in complex abdominal wall repair and for the surgical repair of damaged or ruptured soft tissue.
In January 2016, Integra LifeSciences Corporation’s omnigraft dermal regeneration matrix received new indication from the U.S. Food and Drug Administration (U.S. FDA) to treat certain diabetic foot ulcers
REPORT OUTLINE:
- The report provides granular level information about the market size, regional market share and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. EXECUTIVE SUMMARY
2. GLOBAL DERMAL GRAFTS MARKET INTRODUCTION
2.1. Global Dermal Grafts Market– Taxonomy
2.2. Global Dermal Grafts Market–Definitions
2.2.1. Equipment Type
2.2.2. Application
3. GLOBAL DERMAL GRAFTS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Dermal Grafts Market Dynamics – Factors Impact Analysis
3.6. Global Dermal Grafts Market– Recent Market Introductions
4. GLOBAL DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY EQUIPMENT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Knives Dermatomes
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Electric Dermatomes
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. General Surgical Instruments
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Consumables
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Air Dermatomes
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY GRAFT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Autologous
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Isogenic
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Allogeneic
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Xenogeneic
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Prosthetic
6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY THICKNESS, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Split Thickness
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Full Thickness
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Composite Graft
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Burns
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Extensive Wound
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Skin Cancer
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Infection
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Others
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. Hospitals
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Dermatology Clinics
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Ambulatory Surgical Centers
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
10. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. North America
10.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Region, 2017 – 2023
11. NORTH AMERICA DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.1.1. Knives Dermatomes
11.1.1.2. Electric Dermatomes
11.1.1.3. General Surgical Instruments
11.1.1.4. Consumables
11.1.1.5. Air Dermatomes
11.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Autologous
11.1.2.2. Isogenic
11.1.2.3. Allogeneic
11.1.2.4. Xenogeneic
11.1.2.5. Prosthetic
11.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Split Thickness
11.1.3.2. Full Thickness
11.1.3.3. Composite Graft
11.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Burns
11.1.4.2. Extensive Wound
11.1.4.3. Skin Cancer
11.1.4.4. Infection
11.1.4.5. Others
11.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.5.1. Hospitals
11.1.5.2. Dermatology Clinics
11.1.5.3. Ambulatory Surgical Centers
11.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.1.6.1. U.S.
11.1.6.2. Canada
11.1.7. North America Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
11.1.8. North America Dermal Grafts Market Dynamics – Trends
12. EUROPE DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.1.1. Knives Dermatomes
12.1.1.2. Electric Dermatomes
12.1.1.3. General Surgical Instruments
12.1.1.4. Consumables
12.1.1.5. Air Dermatomes
12.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Autologous
12.1.2.2. Isogenic
12.1.2.3. Allogeneic
12.1.2.4. Xenogeneic
12.1.2.5. Prosthetic
12.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Split Thickness
12.1.3.2. Full Thickness
12.1.3.3. Composite Graft
12.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Burns
12.1.4.2. Extensive Wound
12.1.4.3. Skin Cancer
12.1.4.4. Infection
12.1.4.5. Others
12.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.5.1. Hospitals
12.1.5.2. Dermatology Clinics
12.1.5.3. Ambulatory Surgical Centers
12.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.6.1. Germany
12.1.6.2. UK
12.1.6.3. France
12.1.6.4. Spain
12.1.6.5. Italy
12.1.6.6. Russia
12.1.6.7. Poland
12.1.6.8. Rest of Europe
12.1.7. Europe Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
12.1.8. Europe Dermal Grafts Market Dynamics – Trends
13. ASIA-PACIFIC DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.1.1. Knives Dermatomes
13.1.1.2. Electric Dermatomes
13.1.1.3. General Surgical Instruments
13.1.1.4. Consumables
13.1.1.5. Air Dermatomes
13.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Autologous
13.1.2.2. Isogenic
13.1.2.3. Allogeneic
13.1.2.4. Xenogeneic
13.1.2.5. Prosthetic
13.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Split Thickness
13.1.3.2. Full Thickness
13.1.3.3. Composite Graft
13.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Burns
13.1.4.2. Extensive Wound
13.1.4.3. Skin Cancer
13.1.4.4. Infection
13.1.4.5. Others
13.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.5.1. Hospitals
13.1.5.2. Dermatology Clinics
13.1.5.3. Ambulatory Surgical Centers
13.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
13.1.6.1. Japan
13.1.6.2. China
13.1.6.3. India
13.1.6.4. ASEAN
13.1.6.5. Australia & New Zealand
13.1.6.6. Rest of Asia-Pacific
13.1.7. Asia-Pacific Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
13.1.8. Asia-Pacific Dermal Grafts Market Dynamics – Trends
14. LATIN AMERICA DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.1.1. Knives Dermatomes
14.1.1.2. Electric Dermatomes
14.1.1.3. General Surgical Instruments
14.1.1.4. Consumables
14.1.1.5. Air Dermatomes
14.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.2.1. Autologous
14.1.2.2. Isogenic
14.1.2.3. Allogeneic
14.1.2.4. Xenogeneic
14.1.2.5. Prosthetic
14.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.3.1. Split Thickness
14.1.3.2. Full Thickness
14.1.3.3. Composite Graft
14.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.4.1. Burns
14.1.4.2. Extensive Wound
14.1.4.3. Skin Cancer
14.1.4.4. Infection
14.1.4.5. Others
14.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.5.1. Hospitals
14.1.5.2. Dermatology Clinics
14.1.5.3. Ambulatory Surgical Centers
14.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.6.1. Brazil
14.1.6.2. Mexico
14.1.6.3. Argentina
14.1.6.4. Venezuela
14.1.6.5. Rest of Latin America
14.1.7. Latin America Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
14.1.8. Latin America Dermal Grafts Market Dynamics – Trends
15. MIDDLE EAST & AFRICA DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
15.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.1.1.1. Knives Dermatomes
15.1.1.2. Electric Dermatomes
15.1.1.3. General Surgical Instruments
15.1.1.4. Consumables
15.1.1.5. Air Dermatomes
15.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.1.2.1. Autologous
15.1.2.2. Isogenic
15.1.2.3. Allogeneic
15.1.2.4. Xenogeneic
15.1.2.5. Prosthetic
15.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.1.3.1. Split Thickness
15.1.3.2. Full Thickness
15.1.3.3. Composite Graft
15.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.1.4.1. Burns
15.1.4.2. Extensive Wound
15.1.4.3. Skin Cancer
15.1.4.4. Infection
15.1.4.5. Others
15.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.1.5.1. Hospitals
15.1.5.2. Dermatology Clinics
15.1.5.3. Ambulatory Surgical Centers
15.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.1.6.1. Gulf Cooperation Council (GCC) Countries
15.1.6.2. Israel
15.1.6.3. South Africa
15.1.6.4. Rest of MEA
15.1.7. MEA Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
15.1.8. MEA Dermal Grafts Market Dynamics – Trends
16. COMPETITION LANDSCAPE
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Organogenesis, Inc. (U.S.)
16.2.2. Stratatech Corp. (U.S)
16.2.3. Avita Medical (U.K.)
16.2.4. ConvaTec Group plc. (U.K.)
16.2.5. Coloplast (Denmark)
16.2.6. B. Braun Holding GmbH & Co. KG (B.Braun Melsungen AG) (Germany)
16.2.7. Medtronic (Stratatech Corporation) (U.S.)
16.2.8. Zimmer Biomet. (U.S.)
16.2.9. Nouvag AG (Switzerland)
16.2.10. Tissue Regenix Group PLC (U.K)
16.2.11. Allergan Plc (Ireland)
17. RESEARCH METHODOLOGY
18. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL DERMAL GRAFTS MARKET INTRODUCTION
2.1. Global Dermal Grafts Market– Taxonomy
2.2. Global Dermal Grafts Market–Definitions
2.2.1. Equipment Type
2.2.2. Application
3. GLOBAL DERMAL GRAFTS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Dermal Grafts Market Dynamics – Factors Impact Analysis
3.6. Global Dermal Grafts Market– Recent Market Introductions
4. GLOBAL DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY EQUIPMENT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Knives Dermatomes
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Electric Dermatomes
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. General Surgical Instruments
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Consumables
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Air Dermatomes
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY GRAFT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Autologous
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Isogenic
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Allogeneic
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Xenogeneic
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Prosthetic
6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY THICKNESS, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Split Thickness
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Full Thickness
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Composite Graft
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Burns
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Extensive Wound
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Skin Cancer
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Infection
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Others
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. Hospitals
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Dermatology Clinics
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Ambulatory Surgical Centers
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
10. GLOBAL DERMAL GRAFTS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. North America
10.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Region, 2017 – 2023
11. NORTH AMERICA DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.1.1. Knives Dermatomes
11.1.1.2. Electric Dermatomes
11.1.1.3. General Surgical Instruments
11.1.1.4. Consumables
11.1.1.5. Air Dermatomes
11.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Autologous
11.1.2.2. Isogenic
11.1.2.3. Allogeneic
11.1.2.4. Xenogeneic
11.1.2.5. Prosthetic
11.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Split Thickness
11.1.3.2. Full Thickness
11.1.3.3. Composite Graft
11.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Burns
11.1.4.2. Extensive Wound
11.1.4.3. Skin Cancer
11.1.4.4. Infection
11.1.4.5. Others
11.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.5.1. Hospitals
11.1.5.2. Dermatology Clinics
11.1.5.3. Ambulatory Surgical Centers
11.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.1.6.1. U.S.
11.1.6.2. Canada
11.1.7. North America Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
11.1.8. North America Dermal Grafts Market Dynamics – Trends
12. EUROPE DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.1.1. Knives Dermatomes
12.1.1.2. Electric Dermatomes
12.1.1.3. General Surgical Instruments
12.1.1.4. Consumables
12.1.1.5. Air Dermatomes
12.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Autologous
12.1.2.2. Isogenic
12.1.2.3. Allogeneic
12.1.2.4. Xenogeneic
12.1.2.5. Prosthetic
12.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Split Thickness
12.1.3.2. Full Thickness
12.1.3.3. Composite Graft
12.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Burns
12.1.4.2. Extensive Wound
12.1.4.3. Skin Cancer
12.1.4.4. Infection
12.1.4.5. Others
12.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.5.1. Hospitals
12.1.5.2. Dermatology Clinics
12.1.5.3. Ambulatory Surgical Centers
12.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.6.1. Germany
12.1.6.2. UK
12.1.6.3. France
12.1.6.4. Spain
12.1.6.5. Italy
12.1.6.6. Russia
12.1.6.7. Poland
12.1.6.8. Rest of Europe
12.1.7. Europe Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
12.1.8. Europe Dermal Grafts Market Dynamics – Trends
13. ASIA-PACIFIC DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.1.1. Knives Dermatomes
13.1.1.2. Electric Dermatomes
13.1.1.3. General Surgical Instruments
13.1.1.4. Consumables
13.1.1.5. Air Dermatomes
13.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Autologous
13.1.2.2. Isogenic
13.1.2.3. Allogeneic
13.1.2.4. Xenogeneic
13.1.2.5. Prosthetic
13.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Split Thickness
13.1.3.2. Full Thickness
13.1.3.3. Composite Graft
13.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Burns
13.1.4.2. Extensive Wound
13.1.4.3. Skin Cancer
13.1.4.4. Infection
13.1.4.5. Others
13.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.5.1. Hospitals
13.1.5.2. Dermatology Clinics
13.1.5.3. Ambulatory Surgical Centers
13.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
13.1.6.1. Japan
13.1.6.2. China
13.1.6.3. India
13.1.6.4. ASEAN
13.1.6.5. Australia & New Zealand
13.1.6.6. Rest of Asia-Pacific
13.1.7. Asia-Pacific Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
13.1.8. Asia-Pacific Dermal Grafts Market Dynamics – Trends
14. LATIN AMERICA DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.1.1. Knives Dermatomes
14.1.1.2. Electric Dermatomes
14.1.1.3. General Surgical Instruments
14.1.1.4. Consumables
14.1.1.5. Air Dermatomes
14.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.2.1. Autologous
14.1.2.2. Isogenic
14.1.2.3. Allogeneic
14.1.2.4. Xenogeneic
14.1.2.5. Prosthetic
14.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.3.1. Split Thickness
14.1.3.2. Full Thickness
14.1.3.3. Composite Graft
14.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.4.1. Burns
14.1.4.2. Extensive Wound
14.1.4.3. Skin Cancer
14.1.4.4. Infection
14.1.4.5. Others
14.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.5.1. Hospitals
14.1.5.2. Dermatology Clinics
14.1.5.3. Ambulatory Surgical Centers
14.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.6.1. Brazil
14.1.6.2. Mexico
14.1.6.3. Argentina
14.1.6.4. Venezuela
14.1.6.5. Rest of Latin America
14.1.7. Latin America Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
14.1.8. Latin America Dermal Grafts Market Dynamics – Trends
15. MIDDLE EAST & AFRICA DERMAL GRAFTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
15.1.1. Equipment Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.1.1.1. Knives Dermatomes
15.1.1.2. Electric Dermatomes
15.1.1.3. General Surgical Instruments
15.1.1.4. Consumables
15.1.1.5. Air Dermatomes
15.1.2. Graft Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.1.2.1. Autologous
15.1.2.2. Isogenic
15.1.2.3. Allogeneic
15.1.2.4. Xenogeneic
15.1.2.5. Prosthetic
15.1.3. Thickness Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.1.3.1. Split Thickness
15.1.3.2. Full Thickness
15.1.3.3. Composite Graft
15.1.4. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.1.4.1. Burns
15.1.4.2. Extensive Wound
15.1.4.3. Skin Cancer
15.1.4.4. Infection
15.1.4.5. Others
15.1.5. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.1.5.1. Hospitals
15.1.5.2. Dermatology Clinics
15.1.5.3. Ambulatory Surgical Centers
15.1.6. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.1.6.1. Gulf Cooperation Council (GCC) Countries
15.1.6.2. Israel
15.1.6.3. South Africa
15.1.6.4. Rest of MEA
15.1.7. MEA Dermal Grafts Market- Opportunity Analysis Index - By Equipment Type, By Application, By Thickness, By Graft Type, By End User, and Country, 2017 – 2023
15.1.8. MEA Dermal Grafts Market Dynamics – Trends
16. COMPETITION LANDSCAPE
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Organogenesis, Inc. (U.S.)
16.2.2. Stratatech Corp. (U.S)
16.2.3. Avita Medical (U.K.)
16.2.4. ConvaTec Group plc. (U.K.)
16.2.5. Coloplast (Denmark)
16.2.6. B. Braun Holding GmbH & Co. KG (B.Braun Melsungen AG) (Germany)
16.2.7. Medtronic (Stratatech Corporation) (U.S.)
16.2.8. Zimmer Biomet. (U.S.)
16.2.9. Nouvag AG (Switzerland)
16.2.10. Tissue Regenix Group PLC (U.K)
16.2.11. Allergan Plc (Ireland)
17. RESEARCH METHODOLOGY
18. KEY ASSUMPTIONS AND ACRONYMS